Spontaneous tumours of the central nervous system (CNS) are rare in mice and occur with an overall incidence of about 0.01% (Swenberg, 1982; Morgan et al, 1984) . The VM mouse strain is unique in this regard by expressing a high incidence (about 1.5%) of spontaneous CNS tumours that appear histologically as astrocytomas (Fraser, 1971 (Fraser, , 1986 . The VM brain tumour described here is highly metastatic and its ganglioside content is significantly influenced by in vivo and in vitro growth environments.
MATERIALS AND METHODS

Mice
VM mice were obtained originally as a gift from Dr George Carlson, McLaughlin Research Institute, Montana. All VM mice used in this study were propagated in the animal room of the Biology Department, Boston College, using animal husbandry conditions described previously (Flavin et al, 1991) . A 425-dayold mouse from this colony showed enlargement of the head, lethargy and tremor. This mouse was killed by cervical dislocation and a tumour was grossly identified in a cerebral hemisphere showing a poorly defined 3 × 1 × 1 mm mass with regions of softening. The tumour was minced, suspended in phosphate-buffered saline (PBS), and was then implanted intracranially (i.c.) into 3 syngeneic VM mice. After 3 i.c. passages of the original tumour, serial subcutaneous (s.c.) transplants into the flank were initiated as described previously (El-Abbadi and Seyfried, 1994) . Flank tumours became grossly evident within 8-10 days of transplantation, and death usually occurred within 4-6 weeks. VM mice, approximately 2-3 months of age, were used as tumour recipients. All animal use procedures were in accordance with the National
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Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Care Committee. Also, these procedures meet the standards required by the UKCCCR guidelines.
Histological analysis
Complete autopsies were performed to characterize the VM tumour and its metastatic involvement at 16, 20 and 30 days after flank implantation of the tumour tissue. Routine haematoxylin and eosin (H&E) staining was used to assess the histological appearance of primary and metastatic lesions. Immunohistochemical techniques were performed on both fresh-frozen and paraffinembedded tumour tissues using the standard 3-step indirect peroxidase-antiperoxidase method (Sternberger, 1979) . Primary antibodies were used for immunohistological analysis of the following proteins (a) neuroectodermal S-100 protein (BioGenex) (Kahn et al, 1983) ; (b) neuron-specific enolase (NSE) (Vinores et al, 1984) ; (c) neurofibrillary protein (NFP) (BioGenex) (Schlaepfer, 1987) ; (d) glial fibrillary acidic protein (GFAP) (Eng, 1985) ; (e) leukocyte common antigen (LCA) (Dako and ATCC) (Powers et al, 1992) ; (f) Mac-1α (Sanchez Madrid et al, 1983) ; (g) B cell surface glycoprotein (B 220) (Coffman and Weissman, 1981) ; and (h) intercellular adhesion molecule (ICAM-1) (Said et al, 1979) . The antibodies were titrated against known positive tissues to determine the optimal concentrations to be used. For ultrastructural examination, the tumour tissue was fixed for 2 h at room temperature with 2.5% glutaraldehyde in 0.2 M cacodylate buffer (pH 7.2). Following post fixation in 2% osmium tetroxide for one hour at 4˚C, the tissue was dehydrated and embedded in an epon mixture, sectioned, and stained in uranyl acetate and lead citrate for 15 min and 10 min, respectively. Tissue sections were examined using a Philips 300 electron microscope.
Ganglioside analysis
The solid tumours, normal mouse brains, and cultured tumour cells were frozen at -20˚C, and were then lyophilized to remove water. Gangliosides were isolated and purified by our previously described methods (Seyfried et al, 1978 (Seyfried et al, , 1987 . The purified gangliosides were treated with mild base and then desalted using C-18 Bond Elute columns. Quantification of N-acetylneuraminic acid (NeuAc) and N-glycolylneuraminic acid (NeuGc) was determined using a gas-liquid chromatography procedure (Yu and Ledeen, 1970) . Sialic acid concentration was expressed as µg 100 mg -1 dry weight. The distribution of tumour gangliosides was examined using high performance thin-layer chromatography (HPTLC) (Whatman HPK silica gel) according to the method of Ando et al, 1978 . The mouse brain tumour gangliosides were compared with gangliosides isolated from the cerebral cortex of normal adult mice and with purified GM3, GM3-NeuGc, GM2, GM2-NeuGc, GM1, GD3, GD1a, GT1a, GD1b, GT1b, and GQ1b isolated from mouse, bovine and human tissues by the method of Ando and Yu Yu, 1977, 1979) . The conditions for HPTLC development are described in Figure 3 .
Ganglioside biosynthesis in cultured tumour cells
The VM tumour cell line was established from the flank growing tumour as previously described for other mouse brain tumours (Seyfried et al, 1992; El-Abbadi and Seyfried, 1994) . Ganglioside studies were conducted on confluent cell cultures that had a minimum of 10 passages. The cells were grown in T-75 cultured flasks until preconfluency. An aliquot of 14 C-galactose (New England Nuclear) equivalent to 3-5 µCi was evaporated to dryness under N 2 and resuspended in 10 ml of complete Dulbecco's modified Eagle medium (DMEM). After passage through a sterile filter, the radiolabel-containing medium was fed to the cells. The cells were grown for 48 h (confluency stage) at 37˚C. The medium containing 14 C-galactose was discarded and the flask rinsed 3 × with 5 ml of sterile, cold PBS. Next, the cells were trypsinized, collected in cold, sterile PBS, and centrifuged for 3 min at 2000 rpm. The pellet was washed twice with PBS, frozen, and finally lyophilized to dryness. Radiolabled gangliosides, synthesized by the cells, were isolated and purified as described above. Prior to ganglioside isolation, about 10 µg of unlabelled mouse brain ganglioside sialic acid were added to each sample as carrier. Approximately 3800 dpm of 14 C-labelled gangliosides were spotted on the HPTLC plate.
Gangliosides from the VM cell line were treated with Clostridium perfringens neuraminidase (Type V). Neuraminidase removes terminal sialic residues from gangliosides and will convert hematosides (GM3 and GD3) to lactosylceramide, and polysialogangliosides to GM1 (Ando and Yu, 1977) . Gangliosides GM1 and GM2 are mostly unaffected by neuraminidase treatment since they carry an internal sialic acid. The enzymatic hydrolysis was done as previously described (Ando and Yu, 1977 ). An aliquot of 5800 dpm of the radiolabelled purified tumour cell gangliosides was dried under N 2 , then dissolved in 140 µl of 0.1 M sodium acetate buffer (pH 5.0). Next, 50 µl of neuraminidase (1 unit ml -1 buffer) and 15 µl of 2% Triton CF-54 were added and the mixture was incubated for 24 hours at 37˚C in a shaking water bath. The reaction was stopped by boiling the mixture for 4 minutes. The reaction product was treated with mild base (0.1 N NaOH), desalted, resuspended in C:M (1:1) and finally spotted on HPTLC. Autoradiography of labelled gangliosides was performed by exposing the HPTLC plate to Hyperfilm-3 H (Amersham, Arlington Heights, IL) for 14 days at room temperature. The exposed film was then developed for 5 min and fixed for 4 minutes in Kodak GBX developer and fixer.
RESULTS
Histological analysis
Gross examination of the flank implanted tumours disclosed a whitish, solid, lobulated mass with areas of necrosis. Metastases of the tumour to brain, liver, spleen, and regional lymph were noted at the complete autopsy. Metastases to other organs were identified only by histologic examination. The most common and earliest sites to become involved with metastatic tumour were the brain, spleen, regional lymph nodes, vertebrae and spinal cord. Brain metastases were malignant and metastatic when transplanted subcutaneously into the flanks of other VM mice. Interestingly, no metastases occurred if the tumour was maintained through intracranial transplantation. The gross autopsy findings are summarized in Table 1 .
By light microscopy, the tumour was diffusely infiltrating, highly cellular, and had a relatively uniform appearance ( Figure  1A ). The tumour cells had small amounts of cytoplasm, were poorly differentiated, and were supported by a delicate fibrovascular stroma. The tumour cell nuclei were centrally located, round or slightly cleaved, and contained coarse chromatin with prominent nucleoli. Mitotic figures and regions of necrosis were frequently seen, but nuclear pleomorphism was mild. The histologic features of the metastatic tumour foci in other organs were basically the same as those of the flank tumours. All but one animal had brain involvement with multiple foci of metastases consisting of diffuse infiltration of superficial cortex, perivascular Virchow-Robin's spaces of the grey and white matter, and subependymal regions (Figure 1B and C) . No metastases to the vertebrae and spinal cord were seen after 16 days, but were present in all animals 20 and 30 days after flank implantation. In affected animals there was infiltration of tumour cells into dura mater of the spinal cord and peripheral nerve root ( Figure 1D ).
Organomegaly at autopsy identified early tumour involvement in regional lymph nodes and spleen. Metastases to liver and lung occurred later. Involvement of kidney was sporadic, occurring in at least 1 of 3 animals at each time following implantation. Microscopic examination disclosed multiple subcapsular metastases of the liver and diffuse infiltration of tumour cells into the sinusoids of the regional lymph nodes and spleen. Subcapsular and cortical metastases were noted in the kidney. The tumour involved the muscle of the flank near the implantation site suggesting direct invasion of the tumour cells into neighbouring muscle. The tumour cells also infiltrated into the subcutaneous fatty tissue of the flank. A pericardial metastasis was noted in one animal.
Staining for all neuroectodermal, neuronal, and glial markers (S-100, NSE, NFP and GFAP) were negative in both the implanted flank tumours and in the secondary metastatic tumours. The lymphoid markers (LCA) were mostly negative. In the metastatic spleen, however, there was a weakly positive reaction against B-220 (B lymphocyte marker) and a few positive cells were seen with Mac-1α (macrophage marker) and with ICAM-1 (proliferating lymphocytes and endothelial cells (not shown).
By electron microscopy, the tumour consisted of cells (15 to 20 µm in diameter) that had regular, slightly indented nuclei ( Figure 2A ). These cells contained densely clumped heterochromatin, prominent nucleoli, and had scant cytoplasm with only a small number of cytoplasmic organelles (Figure 2A and 2B) . Groups of tumours cells were surrounded by attenuated fibroblasts with rough endoplasmic reticulum and long fibrillary cytoplasmic processes that were interposed between the tumour cells. The processes mimicked subplasmalemmal densities ( Figure 2B ).
Frequent mitotic figures were noted. No intermediate filaments, microtubules, neurosecretory granules or cell processes were seen. The tumour cells had smooth, closely apposed membranes with no specific junctional structures ( Figure 2C ).
Ganglioside analysis
The ganglioside sialic acid content of the VM tumour and cultured VM tumour cells is shown in Table 2 . The total ganglioside sialic acid content of the s.c. and i.c. VM tumours was significantly lower than the content of the normal VM mouse brain (337.1 ± 10.5 µg NeuAc/100 mg dry weight; n = 3). No NeuGc containing gangliosides were found in the brain. The ganglioside content in the s.c. tumour was very low and consisted mostly of NeuGccontaining gangliosides. The total sialic acid content was higher in the i.c. tumour than in s.c. tumour. This was due to a significant increase in NeuAc-containing gangliosides. This increase comes from the contamination of the tumour tissue with ganglioside-rich tissue from normal brain as we previously described for other mouse brain tumours (Seyfried et al, 1987; El-Abbadi and Seyfried, 1994) . Normal neural tissue also contributes to the higher NeuAc ganglioside content in the brain metastasis (brain met.) than in s.c. tumour.
The i.c. tumour and the brain met. contained several gangliosides that co-migrated on HPTLC with mouse brain gangliosides (compare lanes 3, 4 and 6 in Figure 3) . Several of these gangliosides (GD1a, GD1b, GT1b, and GQ1b) were absent or reduced in the s.c. tumour (lane 5). Most of these brain gangliosides originate from mouse brain tissue surrounding or entrapped within the tumour (Seyfried et al, 1987; El-Abbadi and Seyfried, 1994) . The ganglioside patterns of the i.c. tumour and the brain met. were similar (lanes 4 and 6, respectively). Furthermore, these patterns represented a composite of the brain pattern (lane 3) and the s.c. tumour pattern (lane 5). The ganglioside pattern of the s.c. tumour was complex and contained several gangliosides that did not migrate on HPTLC with standard brain gangliosides (lane 5). A prominent band was seen migrating in the region of GM1b and multiple bands migrated in the region of GD1a/GT1a.
Striking differences in ganglioside content were found between the VM tumour grown in vivo and in vitro. The total ganglioside content and the content of NeuAc-containing gangliosides was about 20-fold higher and 70-fold higher, respectively, in the cultured cells than in the s.c. tumour (Table 2 ). In contrast to the s.c. tumour, no NeuGc-containing gangliosides were detected in the cultured VM cells. GM3-NeuAc, GM2-NeuAc, GM1 (minor ganglioside), and GD1a were the predominant gangliosides in the VM cultured cells (Figure 4 , lane 4). The same gangliosides were radiolabelled when the cells were grown in media containing The products of neuraminidase treatment of the radiolabelled gangliosides isolated from cultured VM cells is shown in Figure 4 (lane 6). Neuraminidase treatment converted several gangliosides to more simple structures. Specifically, the hydrolysis resulted in appearance of a double band in the lactosyl ceramide region, the disappearance of the double bands migrating with gangliosides GM3-NeuAc and GD1a, and an increase in the intensity of the double band migrating with GM1. These results indicate that GM3, GM2, GM1 and GD1a are the major gangliosides synthesized by the cultured VM tumour cells. Furthermore, the double band appearance of these gangliosides arises from heterogeneity in ceramide structure as described previously (Seyfried et al, 1987; El-Abbadi and Seyfried, 1994; Bai and Seyfried, 1997) . A minor double band appeared above GM3 that migrated with standard GA2 (lane 6). The presence of Triton CF-54 in the neuraminidase reaction allows the neuraminidase to partially hydrolyse the internal sialic acid of GM2, thus producing GA2 (Li et al, 1980) . vivo selection of brain colonizing variants from tumour cell lines that routinely metastasize to nonneural organs (Bosmann et al, 1973; Brunson et al, 1978; Conley, 1984; Schackert et al, 1988) . Hence, this new VM tumour should be useful as a natural model for human metastatic cancer. Although this VM tumour is highly metastatic when implanted subcutaneously, it does not metastastize to non-CNS organs when implanted into the brain. Extracranial metastasis is also generally rare for most primary human brain tumours (Duffy, 1983; Shapiro, 1986; Pedersen et al, 1994; Vural et al, 1996) . The explanation for this is unknown, but it may be related to the immunologically privilaged nature of the brain or to the inability of VM cells to adhere and/or degrade brain vascular endothelium. The VM brain tumour may therefore serve as a model for investigating these processes.
The poorly differentiated appearance the VM tumour cells under light microscopy is consistent with previous observations in other VM tumours (Serano et al, 1980; Pilkington et al, 1985) . Although the VM brain tumours described by H Fraser appeared histologically as astrocytomas (Fraser, 1971 (Fraser, , 1986 , it was not possible for us to classify the metastatic VM brain tumour as an astrocytoma since no positive staining was seen with GFAP, NSE, NFP or S-100 protein. It is important to mention, however, that Fraser examined the histology of primary VM tumours at their site of origin, while we examined the histology of our VM tumour following serial passage. This could account in part for some of the histological differences between studies on VM tumours since tumour microenvironment can influence tumour histology 1-4) . The plate was developed by one ascending run with chloroform:methanol:water that contained 0.02% CaCl 2 :2H 2 O; (55:45:10 by volume). The dried plates were exposed to Hyperfilm-3 H. After autoradiography, the plates were sprayed with the resorcinol reagent to identify lanes with unlabelled gangliosides 12.6 ± 0.9 3.6 ± 0.6 8.9 ± 0.8 I.C. f Cultured VM cells were derived from the solid VM tumour as described in the Materials and Methods.
g ND, not detectable. (Seyfried, 2001) . Our electron microscopic examination also revealed a poorly differentiated tumour with a sparse interstitial matrix and closely apposed cell surface. Based on the weak immunostaining of the VM tumour with B220, we cannot exclude the possibility of lymphoma. Further studies will be needed to better classify this tumour.
The ganglioside content of this tumour was different from that of previously described mouse brain tumours. In contrast to most experimental mouse brain tumours, which contain between 20-70 µg total ganglioside sialic acid/100 mg dry weight when grown subcutaneously in vivo (Seyfried et al, 1987 (Seyfried et al, , 1992 , the total ganglioside sialic acid content of the VM tumour was only about 13 µg. Furthermore, about 70% of this sialic acid was in the form of NeuGc. Our previous studies showed that much of the NeuGccontaining gangliosides found in mouse brain tumours is contributed by the host environment, e.g., serum and tumour-infiltrating macrophages El-Abbadi and Seyfried, 1994; Seyfried et al, 1996 Seyfried et al, , 1998 . Our findings suggest that the total ganglioside content of the neoplastic VM tumour cells is diminished when grown in vivo.
Differences in growth environment (in vivo versus in vitro) significantly influenced the ganglioside content of the metastatic VM tumour. In contrast to the in vivo-grown VM tumour, which contained a low total ganglioside content, the ganglioside sialic acid content of the cultured VM tumour cells was high (Table 2) . Indeed, this content was much higher than that found previously in 20-methylcholanthrene-induced experimental mouse brain tumour cell lines (about 38-82 µg 100 mg -1 dry weight) (Seyfried et al, 1992) . Muthing and coworkers previously reported that differences in the in vitro growth environment could significantly influence the ganglioside composition of mouse lymphoma cells (Muthing et al, 1992) . Differences in growth environment can also influence the ganglioside distribution of human brain tumours (Wikstrand et al, 1994; Fredman et al, 1996) .
It is unlikely that the low ganglioside content of the in vivogrown VM tumour results from a tumour-shedding phenomenon since serum ganglioside content is lower in tumour-bearing VM mice than in nontumour-bearing VM mice (Cotterchio and Seyfried, 1994) . This contrasts with previous findings in the murine AKR lymphoma and ependymoblastoma which shed gangliosides (Ladisch et al, 1987; Manfredi et al, 1999) . Since most gangliosides in serum are derived from the liver, we previously suggested that the low serum ganglioside content in the tumour-bearing VM mice may result from impaired liver function due to liver metastasis (Cotterchio and Seyfried, 1994) . The presence of VM tumour cells in liver supports this possibility.
The low ganglioside content of the in vivo-grown VM tumour may be associated with its high metastatic potential. Support for this comes from previous studies that some metastatic tumours grown in vivo contain a lower total ganglioside content than their nonmetastatic variants (Kloppel et al, 1979; Merritt et al, 1980; Skipski et al, 1981; Niederkorn et al, 1993; Zebda et al, 1995) . Also, an opposite effect is observed for cultured tumour cells where the ganglioside content is generally higher in the metastatic than the nonmetastatic cell lines (Yogeeswaran and Salk, 1981; Yogeeswaran, 1983; Laferte et al, 1987) . Our findings on the metastatic VM brain tumour model are consistent with these observations. Additionally, Ladisch and co-workers recently reported a positive correlation between the ganglioside content of murine melanoma cell lines and the metastatic potential of resulting in vivo tumours (Deng et al, 2000) . The VM tumour may therefore serve as a model for evaluating the role of gangliosides and other glycolipids in tumour cell invasion and metastasis.
